Literature DB >> 25871984

To RIC or not to RIC: that is the question.

M Mohty1, F Malard1.   

Abstract

Mesh：

Year:  2015        PMID： 25871984     DOI： 10.1038/leu.2015.82

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  12 in total

1.  Standard versus alternative myeloablative conditioning regimens in allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia.

Authors:  Andrea Mengarelli; AnnaPaola Iori; Cesare Guglielmi; Atelda Romano; Raffaella Cerretti; Concetta Torromeo; Alessandra Micozzi; Susanna Fenu; Luca Laurenti; Vittorio Donato; Lidia De Felice; William Arcese
Journal:  Haematologica       Date:  2002-01       Impact factor: 9.941

2.  Continuous reduced nonrelapse mortality after allogeneic hematopoietic stem cell transplantation: a single-institution's three decade experience.

Authors:  Florent Malard; Patrice Chevallier; Thierry Guillaume; Jacques Delaunay; Fanny Rialland; Jean-Luc Harousseau; Philippe Moreau; Francoise Mechinaud; Noel Milpied; Mohamad Mohty
Journal:  Biol Blood Marrow Transplant       Date:  2014-04-23       Impact factor: 5.742

3.  Comparing i.v. BU dose intensity between two regimens (FB2 vs FB4) for allogeneic HCT for AML in CR1: a report from the Acute Leukemia Working Party of EBMT.

Authors:  M A Kharfan-Dabaja; M Labopin; A Bazarbachi; R M Hamladji; D Blaise; G Socié; B Lioure; A Bermudez; L Lopez-Corral; R Or; W Arcese; N Fegueux; A Nagler; M Mohty
Journal:  Bone Marrow Transplant       Date:  2014-06-30       Impact factor: 5.483

Review 4.  Long-term physiological side effects after allogeneic bone marrow transplantation.

Authors:  Mohamad Mohty; Jane F Apperley
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2010

5.  A comparative assessment of the curative potential of reduced intensity allografts in acute myeloid leukaemia.

Authors:  N H Russell; L Kjeldsen; C Craddock; A Pagliuca; J A Yin; R E Clark; A Howman; R K Hills; A K Burnett
Journal:  Leukemia       Date:  2014-11-07       Impact factor: 11.528

6.  Impact of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation for acute myeloid leukemia: a report from the Acute Leukemia Working Party of the European group for blood and marrow transplantation.

Authors:  F Baron; M Labopin; D Niederwieser; S Vigouroux; J J Cornelissen; C Malm; L L Vindelov; D Blaise; J J W M Janssen; E Petersen; G Socié; A Nagler; V Rocha; M Mohty
Journal:  Leukemia       Date:  2012-05-22       Impact factor: 11.528

7.  Reduced intensity conditioning allogeneic stem cell transplantation for patients with acute myeloid leukemia: long term results of a 'donor' versus 'no donor' comparison.

Authors:  M Mohty; H de Lavallade; J El-Cheikh; P Ladaique; C Faucher; S Fürst; N Vey; D Coso; A-M Stoppa; J-A Gastaut; C Chabannon; D Blaise
Journal:  Leukemia       Date:  2008-06-26       Impact factor: 11.528

Review 8.  High-dose total body irradiation and myeloablative conditioning before allogeneic hematopoietic cell transplantation: time to rethink?

Authors:  Mohamad Mohty; Florent Malard; Bipin N Savani
Journal:  Biol Blood Marrow Transplant       Date:  2014-09-20       Impact factor: 5.742

9.  Prediction of non-relapse mortality in recipients of reduced intensity conditioning allogeneic stem cell transplantation with AML in first complete remission.

Authors:  J Versluis; M Labopin; D Niederwieser; G Socie; R F Schlenk; N Milpied; A Nagler; D Blaise; V Rocha; J J Cornelissen; M Mohty
Journal:  Leukemia       Date:  2014-05-20       Impact factor: 11.528

10.  Reduced-toxicity conditioning with fludarabine, once-daily intravenous busulfan, and antithymocyte globulins prior to allogeneic stem cell transplantation: results of a multicenter prospective phase 2 trial.

Authors:  Mohamad Mohty; Florent Malard; Didier Blaise; Noel Milpied; Sabine Furst; Resa Tabrizi; Thierry Guillaume; Stéphane Vigouroux; Jean El-Cheikh; Jacques Delaunay; Steven Le Gouill; Philippe Moreau; Myriam Labopin; Patrice Chevallier
Journal:  Cancer       Date:  2014-10-03       Impact factor: 6.860
View more
  1 in total

1.  Reduced-intensity transplants, conventional transplants or chemotherapy for acute myeloid leukemia in 1st remission: who knows; ask your wife?

Authors:  R P Gale
Journal:  Leukemia       Date:  2015-03-24       Impact factor: 11.528
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.